Indiana Attorney Todd Rokita filed a lawsuit this week against pharmaceutical giants Mylan and Pfizer, alleging they conspired to increase prices of a potentially life-saving injectable drug by 600%.
The nationwide shortage of the EpiPen is making people scramble. It’s back to school season, and a nationwide shortage of the EpiPen is making parents scramble. If you're the parent of a child with a ...
Application Receives FDA Authorization to Proceed RALEIGH, NORTH CAROLINA / ACCESS Newswire / October 8, 2025 / Belhaven ...
A proposal by Reps. Doris Matsui, D-Sacramento, and Maxwell Frost, D-Florida, would limit out-of-pocket costs for EpiPens — ...
Research study: Palatinus HN, Johnson MA, Wang HE, Hoareau GL, Youngquist ST. Early intramuscular adrenaline administration ...
NASHVILLE, Tenn. (WSMV/Gray News) - For the first time in more than a hundred years, there’s now an FDA-approved alternative to the Epi-pen. Within the last few weeks, the drug has made it to ...
HealthDay on MSN
Analysis finds adrenaline nasal spray as effective as EpiPen
Adrenaline delivered with liquid or powder nasal sprays is as effective, and sometimes even better, than injected adrenaline, ...
HHS has frozen a rule implemented by former President Donald Trump that requires federally qualified health centers to pass discounts on insulin and epinephrine directly to patients. The rule was ...
Stocktwits on MSN
Aquestive Stock Jumps After-Hours As CEO Sees $1B ‘Blockbuster’ Potential For Oral Allergy Film — Retail Sees Stock As Buyout Candidate
Shares of Aquestive Therapeutics jumped more than 11% in after-hours trading Thursday after CEO Dan Barber said the company’s oral epinephrine film, Anaphylm, could become a “blockbuster” drug with as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback